Table 4 Univariate and multivariate Cox proportional hazard regression models for overall survival.
Variable | Univariate analysis | Multivariate analysis (Model 1) | Multivariate analysis (Model 2) | ||||||
---|---|---|---|---|---|---|---|---|---|
HR | 95% CI | p value | adjusted HR | 95% CI | p value | adjusted HR | 95% CI | p value | |
Sex (male) | 1.21 | 0.58, 2.54 | 0.613 | ||||||
Age, year | 1.04 | 1.00, 107 | 0.048 | 0.98 | 0.94, 1.02 | 0.378 | 1.00 | 0.96, 1.04 | 0.900 |
BMI, kg/m2 | 0.94 | 0.85, 1.03 | 0.185 | ||||||
HTN (absence) | 0.83 | 0.34, 2.05 | 0.690 | ||||||
DM (absence) | 1.79 | 0.79, 4.06 | 0.165 | ||||||
VFA, cm2 | 1.00 | 0.99, 1.00 | 0.409 | ||||||
SFA, cm2 | 1.00 | 0.99, 1.00 | 0.497 | ||||||
SMI, cm2/m2 | 0.98 | 0.94, 1.02 | 0.307 | ||||||
Visceral-to-subcutaneous fat ratio | 0.96 | 0.74, 1.24 | 0.738 | ||||||
Skeletal muscle area, cm2 | 0.99 | 0.98, 1.00 | 0.131 | ||||||
Skeletal muscle density, HU | 0.94 | 0.89, 0.98 | 0.009 | 0.91 | 0.86, 0.97 | 0.003 | |||
Sarcopenia (absence) | 1.25 | 0.59, 2.65 | 0.557 | ||||||
Myosteatosis (absence) | 5.66 | 1.34, 23.88 | 0.018 | 5.02 | 1.09, 23.04 | 0.038 | |||
AAS (100/m2 increment) | 1.02 | 1.01, 1.03 | < 0.001 | 1.03 | 1.01, 1.04 | < 0.001 | 1.02 | 1.01, 1.03 | 0.002 |
Creatinine, mg/dL | 1.00 | 0.91, 1.10 | 0.963 | ||||||
eGFR, mL/min/1.73 m2 | 1.00 | 0.99, 1.02 | 0.846 | ||||||
BUN, mg/dL | 1.01 | 1.00, 1.02 | 0.001 | 1.01 | 1.00, 1.02 | 0.012 | 1.01 | 1.00, 1.02 | 0.019 |
Albumin, g/dL | 0.57 | 0.29, 1.14 | 0.114 | ||||||
CRP elevation (absence) | 1.30 | 0.62, 2.75 | 0.489 |